As reported by the UN News Service, since 2021, when the first malaria vaccine was approved, 24 countries have integrated it into their national immunization programs.
In 2024, seasonal chemoprophylaxis expanded, reaching 54 million children, compared to just 200,000 in 2012. The WHO has certified 47 countries and one territory as malaria-free, including Cabo Verde and Egypt in 2024, with Georgia, Suriname, and Timor-Leste expected to join in 2025.
Despite the successes achieved, 282 million cases of malaria were reported in 2024, resulting in 610,000 deaths. In the WHO African Region, 95% of all malaria deaths were recorded, the majority of which were children under five years old. The mortality rate reached 13.8 per 100,000 population, more than three times the global target of 4.5.
The WHO warns of the increasing resistance of parasites to key medications. Additionally, genetic mutations in parasites reduce the accuracy of rapid tests. Climate change and extreme weather conditions contribute to new outbreaks, while conflicts and instability disrupt healthcare systems.
Experts emphasize that funding for malaria control remains critically low: in 2024, only $3.9 billion was allocated for these purposes. The reduction in funding weakens healthcare systems, leads to the cancellation or postponement of planned screenings, and increases the risk of drug supply disruptions.
Malaria is a life-threatening disease transmitted through the bites of certain species of mosquitoes and is most prevalent in tropical countries.
Infection occurs through the bite of an infected parasite. The disease is not transmitted from person to person.
Malaria symptoms can range from mild to life-threatening; mild symptoms include fever, chills, and headache, while severe manifestations can include weakness, confusion, seizures, and difficulty breathing.
Kyrgyzstan has been officially recognized as free from local malaria transmission. However, cases of imported malaria have been registered from citizens returning from high-incidence regions: from 2020 to 2024, 11 such cases were recorded. Thanks to timely diagnosis and treatment, further spread of the infection was avoided.
